Study Year Factors significantly associated wtih increased survival time in multivariate analysis (p value)
Kilburn 2014 none found
Peterson 2014 KPS>80, absence of prior WBRT
Jung 2013 favorable RTOG RPA class, single metastasis
Sengoz 2013 none found
Kawabe 2012 favorable KPS (0.001), single metastasis (0.012), well controlled primary (0.021)
Leeman 2012 none found
LI 2012 NR
Lin 2012 none found
Yoo 2011 KPS > 70 (0.0001), RPA 1 or 2 (0.0014)
Valery 2011 none found
Hatiboglu 2011 smaller pre-SRS tumor volume (0.008), non-melanoma primary (0.002), no necrosis in pre-SRS MRI (0.04), female sex (0.03), BSBM 2-3 (0.007), SIR > 5 (0.003)
Kelly 2011 none found
Koyfman 2010 greater performance status (0.0009), smaller tumor volume (0.0128)
Samblas 2009 NR
Lorenzoni 2009 no WBRT (0.005), KPS > 80 (0.0025), primary tumor controlled (0.007), favorable BSBM (0.00015)
Kased 2008 single metastasis (0.003), non-melanoma primary (0.003), extracranial disease controlled (0.058)
Hussain 2007 NR
Fuentes 2006 NR
Yen 2006 limited systemic disease (0.0293)
Shuto 2003 NR
Huang 1999 no active extracranial systemic disease (0.0008)
Abbreviations: KPS – Karnofsky performance status, RPA – Radiation Therapy Oncology Group Recursive Partitioning Analysis score, NR – not reported
Table 2: Prognostic factors associated with longer median survival time [1,2,4-22].